Johnson & Johnson (J&J) said that an early-stage trial of JNJ-6143 (previously HLD-0915) found that the novel oral Regulated ...

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is ...

Add Yahoo as a preferred source to see more of our stories on Google. Few words are more dreaded to hear from a doctor than learning that a tumor has been discovered. It's something most people equate ...

Pope Leo XIV's doctors say the lung adenocarcinoma tumor removed Oct. 13 was localized, and a cancer assessment found no further treatment needed.

Chemotherapy selectivity is limited by systemic toxicity. pH‑sensitive nanocarriers exploit tumor acidity as a release ...

Peritoneal metastases, a form of late-stage cancer that has spread to the lining of the abdominal cavity, carry a median ...

Researchers are exploring a revolutionary way to predict a patient's response to immunotherapies by creating a tumor “avatar” ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced new two-year follow up results from ...

Even when given the same drug, some patients respond well while others show little or no response. This is particularly true of immunotherapy. A research team at POSTECH (Pohang University of Science ...

However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may produce ...